FindTrial
Sign In

study to evaluate the effect of bodhivriksha phanta after virechan karma in esssential hypertension

Randomised controlled clinical study of bodhivriksh phanta after virechan karma in essential hypertension - HAKT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025426
Enrollment
42
Registered
2020-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R030- Elevated blood-pressure reading, without diagnosis of hypertension

Interventions

Intervention1: VIRECHANA FOLLOWED BY BODHIVRIKSHA PHANTA PAAN: PATIENT WILL BE GIVEN VIRECHANA WITH TRIVRUTTAVLEHA AFTER DEEPAN-PACHAN, SNEHAPAAN EVAM ABHYANG. AFTER VIRECHAN KARMA SANSARJAN KARMA WIL

Sponsors

UTTARAKHAND AYURVEDA UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: SYSTOLIC BP MORE THEN OR EQUAL TO 130 MM HG DIASTOLIC BP MORE THEN OR EQUAL TO 80 MM HG PATIENT FIT FOR VIRECHANA AND PHANTA PAAN WITH DIAGNOSIS OF ESSENTIAL HYPERTENSION

Exclusion criteria

Exclusion criteria: HYPERTENSION ASSOCIATED WITH CEREBRAL, ENDOCRINAL, RENOVASCULAR COMPLICATIONS UNCONTROLLED DIABETES AND INSULIN DEPENDENT DIABETES SYSTOLIC BP MORE THAN 160 MM HG DIASTOLIC BP >100 MM HG

Design outcomes

Primary

MeasureTime frame
No Improvement 0-25% Mild Improvement 26-50% Moderate Improvement 51-75% Markedly Improvement 76-100%Timepoint: 1 month—

Secondary

MeasureTime frame
exacerbation of parametersTimepoint: 1 month—

Countries

India

Contacts

Public ContactHIMANI

Uttarakhand Ayurveda University

alok.pk09@gmail.com9045087121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026